5e40d61ea04c30e61c60606548082cb8 *DESCRIPTION
094003a14bd0c82787397b2b481f7bb9 *NAMESPACE
2b882a524bd44c4ec07f069ec761fbc7 *R/ta.R
e9d9b850e06e661420f522b761a238da *R/td.R
af366631f7aec675363e0f1969261dac *R/td.calc.R
8438160418b11b278c1861fedb74b92b *R/td.output.R
af4deef7412ac78bc9c339f1bb3c48ec *R/td.sub.R
e69889a62f7f44dfb2a2989e74167acb *data/swisspharma.RData
21da5b5f7bfa8912615aeae6f0c3f735 *man/plot.td.Rd
569e628d808569bd944b7856d413f0ad *man/predict.td.Rd
fe208daad8ef74dde7203ceabee61b17 *man/summary.td.Rd
f57cbe227e83dff612e51501a4d32fa5 *man/swisspharma.Rd
20f54cb505427ddbd5e9cf1b553968f1 *man/ta.Rd
a7a04676edfd76fcc9ae7156f238c78f *man/td.Rd
ea750f05ae96979578a32e58dde0d4a3 *man/tempdisagg-internal.Rd
1da0a67502f25ba689aa0fc5566942e3 *news.txt
